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Abstract
Background: Pasteurella multocida (Pm) is the causative agent of progressive atrophic rhinitis (PAR) and pneumonic 
pasteurellosis (PN) in pigs. Pm is a member of the porcine respiratory complex responsible for important economic loss in 
the pig industry.
Aim: This study aimed to characterize the Pm strains recovered from clinical cases of PN and PAR and to elucidate the 
antibiotic susceptibility profiles of the strains.
Materials and Methods: Sixty strains were characterized molecularly by polymerase chain reaction to determine species-
specific gene, capsular type (A or D), and toxin A production. The agar diffusion method was employed to evaluate antibiotic 
resistance profiles.
Results: We found that 65% of strains belonged to capsular type A or D, and 15% of those were positive to toxA gene. 
The antibiotic susceptibility profiles found were sensitive in decreasing order to: Enrofloxacin, ceftiofur (CTF), ampicillin, 
tilmicosin (TIL), florfenicol (FFN), spectinomycin (SPC), gentamicin, oxytetracycline (OTC), and trimethoprim-
sulfamethoxazole (TMS). Strains were resistant in decreasing order to: Lincomycin (LIN), tylosin (TYL), erythromycin 
(ERY), TMS, SPC, OTC, FFN, TIL, and CTF.
Conclusion: The toxA gene was detected in many Pm isolates from pneumonic lungs. Capsule type A or D was the most 
frequently found among the collected isolates. LIN, TYL, and ERY are the drugs which showed higher percentages of 
resistant isolates.
Keywords: antibiotics susceptibility profiles, molecular characterization, Pasteurella multocida, pig.
Introduction
Progressive atrophic rhinitis (PAR) and 
pneumonic pasteurellosis (PN) in pigs are the main 
diseases caused by Pasteurella multocida (Pm) [1]. 
This agent is part of the porcine respiratory complex 
(PRC) and is responsible for significant economic 
losses at the productive level in porcine farms [2].
Numerous critical genes for Pm virulence have 
been identified in an attempt to elucidate the patho-
genesis of pasteurellosis, which remains as a puzzle 
in many of its host species such as pigs [3-8]. The 
capsule is a key virulence factor in the pathogenesis 
of pasteurellosis in pigs. It has been established, by 
construction of genetically defined mutants, unable 
to synthesize or export the capsule to its surface, 
that virulence of original strains was attenuated 
[9,10]. The identification of capsid biosynthesis 
genes (capA, capB, capD, capE, and capF) led to the 
development of DNA-based typing by polymerase 
chain reaction (PCR) technique [9,10], an alternative 
to the serological methods traditionally employed 
(serogroups A, B, D,  E, and F based on the anti-
genicity of their polysaccharide capsule) [11-13]. 
The dermonecrotic toxin of Pm is a 146 kDa protein 
encoded by the toxA gene responsible for the clinical 
signs and pathogenesis of PAR. The toxigenic strains 
associated with PAR frequently belong to capsular 
type D although toxigenic isolates of capsular type A 
may also be involved in this disease [14-16]. In con-
trast to isolates associated with PAR, Pm isolated 
from PN is generally non-toxigenic capsular type A 
strains [1,4]. However, small proportions of strains 
isolated from lungs resulted to be toxigenic and/or 
belonged to capsular type D [16,17]. Description of 
pneumonia outbreaks caused by Pm in India, affect-
ing various categories of pigs in a group of farms, 
is available [18]. Information about the circulation 
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and characterization of Pm among pigs in Argentina 
[13,19] is limited and outdated. The emergence of 
antibiotic multiresistant Pm strains implies the need 
to carry out permanent surveillance of antimicrobial 
susceptibility profiles [20]. To determine the anti-
biotic resistance profiles of autochthonous swine, 
Pm isolates in Argentine is a permanent challenge. 
Therefore, updated information about circulating 
strains and its susceptibility to antibiotics is neces-
sary to plan adequate control measures against the 
diseases produced by the species.
This study aimed to characterize the attributes 
of virulence and the antimicrobial resistance profiles 
expressed by a collection of Pm strains recovered 
from clinical cases of PN and PAR and to elucidate 
the antibiotic susceptibility profiles of the strains.
Materials and Methods
Ethical approval
To guarantee the correct and careful handling 
of pigs, investigators proceeded according to spec-
ifications of Ethical Guidelines (Internal Ethical 
Committee CICUAE Res. 533/16).
Sampling
Nasal swabs and lung samples (n=115) both 
from diseased animals were received in the Animal 
Health Laboratory of Instituto Nacional de Tecnología 
Agropecuaria (INTA) Estación Experimental 
Agropecuaria Marcos Juarez, in the period 2010-
2014. All samples were taken from commercial inten-
sive farms of the Province of Cordoba in the central 
region of Argentina.
Bacterial isolates
We analyzed 60 isolates of Pm recovered from 
the samples, which were collected through culturing 
nasal swabs and lung samples from pigs with clinical 
cases of PAR and pneumonia, respectively. Samples 
were inoculated onto 6% equine blood agar plates, 
incubated at 37°C for 24 h, and identified by Gram 
staining, morphology (bacilli or coccobacilli), and 
biochemical test: Oxidase (positive), SIM (indole pos-
itive and non-motile), and urease (negative).
DNA purification
DNA from identified strains was extracted using 
commercial kits (Qiagen®), according to manufactur-
er’s instructions. Samples were stored at −20°C. These 
extracts were used as templates for PCR reaction.
Molecular characterization
All Pm isolates (n=60) were analyzed by 
PCR to characterize the following traits: Species-
specific gene of Pm and capability to produce toxin 
type A and capsular type (A and D). In Table-1, 
the gene primers used are listed [21,22]. The PCR 
mixture was composed of 5 µl of DNA 50 µM of 
each primer (Fagos®), 100 µM dNTPs (Promega), 
1.5 µM of MgCl, 1X buffer (5X-Go Taq Promega®). 
and 0.5 U of Taq Polymerase (Promega®) in a final 
volume of 25 µL. Reactions were subjected to one 
initial denaturalization cycle of 94°C for 60 s, fol-
lowed by 30 cycles of 30 s at 94°C denaturation, 30 
s at 58°C (primers annealing), 30 s at 72°C (exten-
sion), and finally, 2 min at 72°C (final extension). 
Reference strains of Pm were used as pathotype 
and positive control reaction (Table-1). For reveal-
ing the amplified products, standard electrophore-
sis in 1% of agarose in Tris-acetate EDTA buffer 
stained with ethidium bromide performed at 100V 
during 30 min was used. Visualization of amplicons 
was made under transilluminator (UV-λ 300nm), 
and the 100 bp ladder was used. Gels were photo-
graphed with a Kodak Easy Share Z7590 camera 
system and evaluated with a Kodak Digital Science 
1D software.
Antibiotic profiles
A disk diffusion method was performed accord-
ing to recommendations of the National Committee 
for Clinical Laboratory Standards (NCCLS, 
2014) [23]. Briefly, 12 different antibiotics were 
assayed: Enrofloxacin (ENR), ceftiofur (CTF), ampi-
cillin (AMP), tilmicosin (TIL), erythromycin (ERY), 
lincomycin (LIN), spectinomycin (SPC), florfenicol 
(FFN), gentamicin (GEN), trimethoprim-sulfame-
thoxazole (TMS), oxytetracycline (OTC), and tylosin 
(TYL). The manufacture guidelines were used for 
inhibition halo interpretation. Multiple antibiotic 
resistance was defined as isolates, showing three or 
more antimicrobial classes resistance.
Statistical analysis
To evaluate associations between variables (anti-
biotic profiles), conglomerates analysis was employed 
with Euclidea’s variables definition, to know the levels 
of variable relation. InfoStat version 2015 [24] soft-
ware was employed (InfoStat®, National University of 
Córdoba, Argentina).
Table-1: Primers sequences of Pm virulence factor.
Virulence factor Description Primer ID Sequence 5×-3× Amplicon size (bp) References
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Results
The 60 strains studied were positive for the 
species-specific PCR of Pm (Figure-1). It was observed 
that 65% of the isolates were capsular type A (32.5%) 
or D (32.5%), while the remaining 35% belonged to 
other capsular types (not determined in this work). It 
was also observed that 16.6% of the studied strains 
were amplified for the ToxA gene (Table-2), beyond 
the associations with pathologies studied.
In relation to the antibiotic susceptibility pro-
files, about 70% of strains showed sensitivity to ENR, 
CEF, AMP, TIL, FFN, SPC, GEN, OTC, and TMS 
(Figure-2). All strains were resistant to LIN, 70% of 
strains showed resistance to TYL, while resistance to 
CEF (7%), AMP (13%), TIL (13%), ERY (48%), SPC 
(20%), FFN (20%), OTC (20%), and TMS (27%) was 
also found. Antibiotics tested are frequently used in 
commercial intensive farms.
Multiple resistance profiles to antibiotics were 
detected. Association between resistance profile and 
pathological condition is shown in Table-3.
Strains isolated from animals with both patho-
logical conditions, PAR and PN, showed extended 
antibiotic multi-resistance profiles (conglomerate 
analysis) (Figure-3).
To analyze the profiles of resistance of isolates, 
a dendrogram was constructed. As shown in Figure-2, 
two principal groups forming two conglomerates were 
found, with a distance of practically two points. The 
conglomerate constituted by LIN (100%), TYL (70%), 
and ERY (48%) are drugs with the highest percentage 
of resistance. The other associations of conglomerate 
cluster of resistance, intermediate susceptibility, and 
sensitivity, in descending order from top to bottom, 
are graphed.
Discussion
Isolation of Pm from PRC is a relatively frequent 
event. However, updated information about character-
istics of strains recovered in our country in terms of 
toxicity, capsular type, or antibiotic resistance profiles 
is limited. The present work provides relevant infor-
mation about these topics from a collection of strains 
isolated from pigs affected by PN or PAR in farms 
from Argentina.
The PCR technique turned out to be rapid and 
reliable to determine the capsular types A and D as 
well as Pm species-specific gene (KMT1), similarly 
to previously reported by other authors [9,10,16,21].
Our results showed that, from 36 isolates associ-
ated with PN, only 19 (53%) resulted as being of cap-
sular type A. Even more, from 24 isolated strains from 
animals affected by PAR, 19 (83%) were found to be 
capsular type D. This association, in terms of disease 
symptoms, macroscopic lesions, and capsular type, 
for both diseases is consistent with previous studies 
where cases of PN were related to capsular type A and 
cases of PAR were related to capsular type D [1,16].
The toxA gene was detected in eight isolates 
associated with PN and only in two isolates associ-
ated with PAR; these findings do not agree with pre-
vious studies [15,25], reporting that toxigenic type A 
Pm is the main causative agent of nasal turbinate 
atrophy in swine. In the present investigation, seven 
strains positive to toxA were isolated from lungs asso-
ciated with PN; however, turbinates from pneumonic 
animals were not inspected so that there is a chance 
that those animals could have been also affected by 
Figure-1: Electrophoresis gel of polymerase chain reaction 
products. Lane 1: CapD; Lane 2: KMT1; Lane 3: CapA; 
Lane 4: Negative control; Lane 5: CapD; Lane 6: Ladder 
(100bp).
Figure-2: Profiles of antibiotic susceptibility of Pasteurella 
multocida strains.
Figure-3: Dendrogram shows conglomerates analysis of 
antibiotic profiles of Pasteurella multocida from progressive 
atrophic rhinitis and pneumonic pasteurellosis cases.
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PAR. Although the role of Pm as the primary agent 
of respiratory infections in PRC is still discussed and 
unclear, the present findings provide some evidence 
concerning involvement of toxigenic Pm in PN. The 
old debate is still open: Could Pm play a primary etio-
logical role in the pathogenesis of porcine pneumonia, 
Table-2: Association of capsular types, presence of toxin, and pathogenicity of Pm isolates.
Strain ID Type A Type D Cap. ND Tox A PN PAR
Pm001 + − − − + −
Pm002 − + − − − +
Pm003 − − + − − +
Pm005 + − − + + −
Pm006 − + − − − +
Pm008 + − − − + −
Pm010 + − − − + −
Pm011 − + − − − +
Pm012 - + - - - +
Pm014 − − + − + −
Pm017 + − − − + −
Pm019 − − + + + −
Pm020 − + − + − +
Pm021 + − − − + −
Pm025 + − − − + −
Pm026 − − + − − +
Pm028 + − − + + −
Pm029 + − − − + −
Pm031 − + − − − +
Pm032 + − − − + −
Pm038 − − + − − +
Pm040 − + − − − +
Pm041 − + − + − +
Pm042 − + − − − +
Pm043 − + − − − +
Pm044 − + − − − +
Pm048 − + − − − +
Pm049 − + − − − +
Pm052 + − − + + −
Pm053 − − + − + −
Pm054 − + − − − +
Pm061 + − − − + −
Pm063 + − − − + −
Pm066 - + - - - +
Pm073 − − + − + −
Pm074 − − + − + −
Pm075 + − − − + −
Pm076 − − + − + −
Pm079 − + − − − +
Pm080 − + − − − +
Pm084 − − + − + −
Pm086 − − + − − +
Pm093 − − + + + −
Pm095 − − + − + −
Pm097 − − + + + −
Pm098 − + − − − +
Pm099 − − + − − +
Pm100 − − + − + −
Pm101 + − − − + −
Pm103 + − − − + −
Pm104 + − − − + −
Pm106 − − + − + −
Pm107 + − − − + −
Pm108 − − + − + −
Pm109 − − + − + −
Pm110 + − − − + −
Pm111 − − + + + −
Pm112 − + − − − +
Pm113 − − + + + −
Pm114 − − + − + −
Total (%) 19 (32.5) 19 (32.5) 22 (35) 10 (16.6) 36 (60) 24 (40)
References - Pm=Pasteurella multocida, PN=Pneumonic pasteurellosis, PAR=Progressive atrophic rhinitis, Cap 
ND=Capsular type not determined
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not always behaving as an opportunistic pathogen as 
cited in other studies? [25]. We considered necessary 
to answer that question, a greater number Pm strains 
from PN be studied in order to deepen the knowledge 
about the role of this pathogen. Isolation from PAR 
cases as well as from PN should be collected and stud-
ied, and also, experimental infection models should be 
mounted to correlate the isolate genetic expression to 
host disease production.
We considered highlighting the importance of 
maintaining continuous surveillance of antibiotic sus-
ceptibility profiles of pathogens such as Pm. This is 
so because of the limited availability of the menu of 
therapeutic agents that are active and whose usage is 
legal to neutralize microorganisms causing PRC. In 
this work, ENR was the unique antibiotic with antimi-
crobial activity against 100% of the strains tested, fol-
lowed by CTF (93.3%), AMP (86.7%), TIL (86.7%), 
and GEN (80%). Similar findings were reported by 
Tigga et al. [18] in India, who found 100% of sen-
sitivity to ENR and GEN; however, TMS and OTC 
results were different. Susceptibilities of 100% of 
strains tested to AMP, CTF, ENR, FFN, tilmicosin, 
and penicillin were communicated in the USA and 
Canada [20]. In contrast, we found a higher propor-
tion of resistant strains to ampicillin (13.3%), FFN 
(13.3%), and TIL (20%) but more susceptible strains 
to OTC (73.3%). In regard to previous work in our 
country, about 13 Pm isolates were found to be sus-
ceptible to ampicillin, CTF, ENR, FFN, GEN, tiam-
ulin, and tetracycline [13]. Moredo et al. [19] found 
percentages of around 35% of strains susceptible to 
ampicillin, tetracycline, ENR, and FFN. Our findings 
partially agree with these reports providing updated 
information concerning the matter. It is possible that 
the resistance to TYL found in our work could be due 
to the massive usage of this drug in the feed. TYL is 
commercially available, being easy to handle through 
the food ration. Even more, it was extensively used 
in respiratory and digestive problems, as well as a 
growth promoter. Although antibiotics with a broad 
spectrum of activity have been registered, we consid-
ered important to remark the increase of resistance and 
intermediate resistance developed by some strains.
Conclusion
In the central region of Argentina, 15% of the 
studied strains, many of which were isolated from 
lungs with diagnosis compatible with PN, possess the 
ToxA gene. Antibiotic resistance profiles showed that 
LIN, TYL, and ERY are drugs with a higher percent-
age of resistance among strains tested.
Knowledge of the phenotypic characteristics 
of strains of Pm isolated in Argentina is important 
for better control of the diseases produced by the 
organism; however, it would be necessary to analyze 
a greater number of strains within the framework of 
epidemiological studies.
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